Effect of cytotoxic agents and retinoic acid on Myc-N protein expression in neuroblastoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 1, 2010, Pages 86-89

  Aktas, Safiye ^a   Altun, Zekiye ^a   Erbayraktar, Zubeyde ^a   Aygun, Nevim ^a   Olgun, Nur ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Myc N; Neuroblastoma; Retinoic acid

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MYC PROTEIN; RETINOIC ACID; VINCRISTINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CHILD; GENE AMPLIFICATION; GENE EXPRESSION; HUMANS; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; TRETINOIN; VINCRISTINE;

EID: 76149104589     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181aa432d     Document Type: Article

References (16)

1. Olgun N, Kansoy S, Aksoylar S, et al. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol. Pediatr Hematol Oncol. 2003;20:211-218.
2. Cetinkaya C, Hultquist A, Su Y, et al. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in Myc-N-amplified neuroblastoma cells. Mol Cancer Ther. 2007;6:2634-2641.
3. Altungoz O, Aygun N, Tumer S, et al. Correlation of modified Shimada classification with Myc-N and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma. Cancer Genet Cytogenet. 2007;172:113-119.
4. Ozer E, Altungoz O, Unlu M, et al. Association of Myc-N amplification and 1p deletion in neuroblastomas with high tumor vascularity. Appl Immunohistochem Mol Morphol. 2007;15:181-186.
5. Reynolds CP. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. Curr Oncol Rep. 2000;2:511-518.
6. Reynolds CP, Matthay KK, Villablanca JG, et al. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 2003;197:185-192.
7. Park JR, Villablanca JG, London WB, et al. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cisretinoic acid: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008;52:44-50.
8. Czeczuga-Semeniuk E, Anchim T, Dziecio J, et al. Can transforming growth factor-beta 1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells? Acta Biochim Pol. 2004;51:733-745.
9. Kanemaru KK, Tuthill MC, Takeuchi KK, et al. Retinoic acid induced downregulation of Myc-N is not mediated through changes in Sp1/Sp3. Pediatr Blood Cancer. 2008;50:806-811.
10. Cernaianu G, Brandmaier P, Scholz G, et al. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit. J Pediatr Surg. 2008;43:1284-1294.
11. AktaşS, Kargi A, Olgun N, et al. Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma. Lymphatic Res Biol. 2007;5:175-182.
12. Oktem G, Vatansever S, Ayla S, et al. Effect of apoptosis and response of extracellular matrix proteins after chemotherapy application on human breast cancer cell spheroids. Oncol Rep. 2006; 15:335-340.
13. Gupta A, Williams BR, Hanash SM, et al. Cellular retinoic acidbinding protein II is a direct transcriptional target of Myc-N in neuroblastoma. Cancer Res. 2006;66:8100-8108.
14. Takatsuka J, Takahashi N, de Luca LM. Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res. 1996;56:675-678.
15. Wainwright LJ, Lasorella A, Iavarone A. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci USA. 2001;98:9396-9400.
16. Chevrier L, Meunier AC, Cochaud S, et al. Vasoactive intestinal peptide decreases Myc-N expression and synergizes with retinoic acid in a human Myc-N-amplified neuroblastoma cell line. Int J Oncol. 2008;33:1081-1089.